VentriPoint Historical Valuation

VPT Stock  CAD 0.18  0.01  5.26%   
Some fundamental drivers such as market cap or VentriPoint Diagnostics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze VentriPoint Diagnostics valuation indicators such as Market Cap of 43.7 M or Working Capital of 751.2 K to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of VentriPoint Diagnostics's future value.

VentriPoint Diagnostics Working Capital

751,187

  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About VentriPoint Valuation Data Analysis

Valuation is the financial process of determining what VentriPoint Diagnostics is worth. VentriPoint Diagnostics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. VentriPoint Diagnostics valuation ratios help investors to determine whether VentriPoint Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VentriPoint with respect to the benefits of owning VentriPoint Diagnostics security.

VentriPoint Diagnostics Valuation Data Chart

At this time, VentriPoint Diagnostics' Market Cap is fairly stable compared to the past year. Enterprise Value is likely to climb to about 42.9 M in 2025, whereas Working Capital is likely to drop slightly above 751.2 K in 2025.

Working Capital

The difference between a company's current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Enterprise Value

Enterprise Value (or EV) is usually referred to as VentriPoint Diagnostics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on VentriPoint Diagnostics debt, but would also pocket its cash. Enterprise Value is more accurate representation of VentriPoint Diagnostics value than its market capitalization because it takes into account all of VentriPoint Diagnostics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.
Most indicators from VentriPoint Diagnostics' valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, VentriPoint Diagnostics' Market Cap is fairly stable compared to the past year. Enterprise Value is likely to climb to about 42.9 M in 2025, whereas Working Capital is likely to drop slightly above 751.2 K in 2025.
 2024 2025 (projected)
Working Capital771.0K751.2K
Market Cap41.6M43.7M

VentriPoint Diagnostics valuation accounts Correlations

VentriPoint Diagnostics Account Relationship Matchups

VentriPoint Diagnostics valuation accounts Accounts

202020212022202320242025 (projected)
Market Cap5.1M6.7M42.1M46.3M41.6M43.7M
Enterprise Value6.2M7.6M37.4M45.4M40.8M42.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VentriPoint Stock Analysis

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.